Synaptogenix Inc (SNPX)

[Amatuer17]

The presentation is interesting - the conclusion about multi-modal action suggest that this drug attacks various adverse areas that cause ALZ - sounds like a silver bullet- clearly too good to be true.

Dr was confident and repeated the claim about reversal. Everyone else is talking about just reducing progression and he is talking about reversal. We will see the topline results quite soon.

Another point - AVXL thinks the homeostasis is the right approach to tackle ALZ, NTRP thinks PKC control is the way forward and BP are banking on beta amyloid.
Not sure who is right.